Bessemer Group
FLGT icon

Bessemer Group’s Fulgent Genetics FLGT Stock Holding History

Bessemer Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14
Closed – – 2562
2025
Q2 		$0 Hold
14
– – ﹤0.01% 2471
2025
Q1 		$0 Buy
+14
New +$238 ﹤0.01% 2536
2024
Q4 		– Sell
-50
Closed -$1K – 2524
2024
Q3 		$1K Buy
+50
New +$1.12K ﹤0.01% 2402
2024
Q1 		– Sell
-40
Closed -$1K – 2093
2023
Q4 		$1K Hold
40
– – ﹤0.01% 2090
2023
Q3 		$1K Sell
40
-31
-44% -$1.06K ﹤0.01% 2075
2023
Q2 		$2K Buy
71
+31
+78% +$1.08K ﹤0.01% 2029
2023
Q1 		$1K Hold
40
– – ﹤0.01% 1855
2022
Q4 		$1K Hold
40
– – ﹤0.01% 1812
2022
Q3 		$2K Hold
40
– – ﹤0.01% 1909
2022
Q2 		$2K Hold
40
– – ﹤0.01% 1740
2022
Q1 		$3K Hold
40
– – ﹤0.01% 1674
2021
Q4 		$4K Buy
+40
New +$3.52K ﹤0.01% 1635

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bessemer Group's FLGT Position: Q3 2025 in Review

Bessemer Group sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 14 shares.

Bessemer Group first reported a position in FLGT in Q4 2021 and held it in 12 quarters. The position peaked at $4K in Q4 2021. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Bessemer Group reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Bessemer Group sold 14 Fulgent Genetics shares in Q3 2025.
  • Bessemer Group first reported a position in Fulgent Genetics in Q4 2021 and held it in 12 quarters.
  • Bessemer Group's Fulgent Genetics position peaked at $4K in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.